Anti-staphylococcal celecoxib derivatives
US9079899B2 · kind B2 · utility
0Cited by
4References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 31, 2011 |
| Grant date | Jul 14, 2015 |
| Priority date | — |
| Expiry date | May 6, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D405/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of treating infection by Staphylococcus in a subject by administering a pharmaceutical composition including a celecoxib derivative of formula I or apharmaceutically acceptable salt thereof is described.The preparation of numerous celecoxib derivatives for testing as potential anti-staphylococcal agents is also described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.